Health and Fitness Health and Fitness
Wed, August 18, 2010
Tue, August 17, 2010

SDIX, Romer Labs Distribution Agreement Extends Accessibility to Advanced Genetically Modified Organism Testing Products


Published on 2010-08-17 06:26:36 - Market Wire
  Print publication without navigation


NEWARK, Del.--([ BUSINESS WIRE ])--SDIXa" (Nasdaq:SDIX), a leading provider of biotechnology-based products and services for a broad range of life science, biotechnology, diagnostic, and food safety applications, today announced it has signed a distribution agreement with Romer Labs® Inc. for SDIXa™s Genetically Modified Organisms (GMO) rapid testing products.

"This agreement once more demonstrates Romer Labs® position as a leading provider of diagnostic solutions in the agriculture, food and feed industries. In addition, Romera™s established kit development and intensive research and development activities make it an attractive cooperation and distribution partner for complimentary products like those from SDIX."

Under terms of the agreement, Romer Labs® will have exclusive global distribution rights outside of Brazil to distribute SDIXa™s [ TraitChek ]® and [ SeedChek ]® GMO test strip products.

TraitChek® and SeedChek® are easy to use, accurate, and affordable GMO detection systems for grain and seed. TraitChek® tests enable rapid testing of grains for GMO at elevators and terminals. Visual results can be seen in 3 to 5 minutes, thereby expediting grain processing. SeedChek® tests and ELISA plates are used to rapidly test seed lots for quality control requirements and leaf tissue in the field. Visual results for SeedChek® can be seen in 3 to 5 minutes.

Transgenic seed varieties are marketed alongside conventional seed varieties. As a result, testing methods to determine the presence or absence of genetic traits is critical. SDIX offers both test strip and microwell ELISA plate test formats to meet the grain and seed testing demands for breeders, as well as grain, seed, and feed producers and consumers.

Tim Lawruk, SDIX Food Safety Market Manager, said, aAs a world leader in diagnostic solutions for the feed and grain safety market, Romer Labs® is an excellent partner for SDIX and this collaborative distribution agreement will quickly provide important benefits to both companies. Romer will have access to SDIXa™s advanced portfolio of rapid GMO detection technologies and SDIX will have access to a significant new global customer base through Romera™s extensive worldwide sales and marketing organization. In addition, it will enable SDIX to focus more of its sales and marketing resources on driving its Food Safety activities.a

According to Michael Prinster, CEO of Romer Labs® Inc., aThe cooperation between SDIX and Romer Labs will be beneficial for both sides. It will allow Romer Labs® to get one step closer to our vision of becoming the number one provider of diagnostic solutions at all stages of the agricultural, food, and feed industry supply chain by being able to offer a range of well established and received GMO tests, in addition to its range of test systems for mycotoxins, food allergens, and veterinary drug residues. It will also allow SDIX immediate access to a global distribution network in the area of food safety via Romer Labs® subsidiaries and distributors.a

Hannes Binder, CEO of Romer Labs® Division Holding GmbH. in Austria, said, aThis agreement once more demonstrates Romer Labs® position as a leading provider of diagnostic solutions in the agriculture, food and feed industries. In addition, Romera™s established kit development and intensive research and development activities make it an attractive cooperation and distribution partner for complimentary products like those from SDIX.a

About Romer Labs ([ www.romerlabs.com ])

Romer Labs®, founded in Washington, MO in the U.S. in 1982, is a leader in diagnostic solutions for food and feed safety. The company has facilities in Austria, Brazil, China, Singapore, United Kingdom, and the USA. Diagnostic solutions offered include test systems for mycotoxins, food allergens, veterinary drug residues, melamine, and GMO testing. In addition, Romer Labs® also offers laboratory services in North America, Europe, and Asia. Romer Labs® also develops, produces and markets a range of standards, reference materials, and calibrants needed for analysis.

Romer Labs® has been a trusted partner for the agriculture, food, and feed industry worldwide for more than 28 years.

About SDIX ([ www.sdix.com ])

SDIX is a biotechnology company, expert at creating advantage by providing a broad range of quality, innovative, and effective immuno-solutions to the Pharmaceutical, Biotechnology, Diagnostics, and Food Safety markets. For nearly 20 years, SDIX has developed antibodies which advance its customersa™ immuno-based work a" reducing time, labor, and costs while increasing accuracy and reliability of results.

SDIX offers a full suite of integrated immuno-solution capabilities including assay design, development, and production. In life science markets, SDIX capabilities are being used to help discover the mechanisms of disease, facilitate the development of new drugs, and provide mechanisms for rapid diagnosis.

This news release may contain forward-looking statements reflecting SDIX's current expectations. When used in this press release, words like aanticipatea, acoulda, aenablea, aestimatea, aintenda, aexpecta, abelievea, apotentiala, awilla, ashoulda, aprojecta, aplana and similar expressions as they relate to SDIX are intended to identify said forward-looking statements. Investors are cautioned that all forward-looking statements involve risks and uncertainties, which may cause actual results to differ from those anticipated by SDIX at this time. Such risks and uncertainties include, without limitation, changes in demand for products, the application of our technologies to various uses, delays in product development, delays in market acceptance of new products, retention of customers and employees, adequate supply of raw materials, inability to obtain or delays in obtaining fourth party or required government approvals, the ability to meet increased market demand, competition, protection of intellectual property, non-infringement of intellectual property, seasonality, and other factors more fully described in SDIX's public filings with the U.S. Securities and Exchange Commission.

Contributing Sources